Published in Ter Arkh on January 01, 1987
Destruction of human cells in tissue culture by lymphocytes from patients with systemic lupus erythematosus. Lancet (1966) 1.43
[Changes in the ultrastructure of the chloride cells of sturgeon during adaptation to a hypertonic medium]. Arkh Anat Gistol Embriol (1975) 0.97
[Binding of dinitrochlorbenzene with skin proteins and use of conjugates for serological diagnosis of contact allergy]. Biull Eksp Biol Med (1970) 0.83
[Expression of Hsp70 and Hdj1 chaperone proteins in human tumor cells]. Vopr Onkol (2004) 0.77
Effect of the age of pregnant females on brain development in the offspring. Bull Exp Biol Med (2004) 0.77
[The functional activity and count of the natural killer cells in patients with recently diagnosed diabetes mellitus types I and II]. Ter Arkh (1989) 0.76
[Perturbations of the vesicle cycle in reticulospinal synapses of axons in lamprey after presynaptic microinjections of GTPgammaS]. Tsitologiia (2007) 0.76
Abolition of natural tolerance and the influence of the chemical allergen beryllium on autoimmune processes. Bull World Health Organ (1974) 0.75
[Activity of short-lived suppressor lymphocytes in rheumatoid arthritis]. Ter Arkh (1985) 0.75
[Immunology of systemic lupus erythematosus (literature review)]. Ter Arkh (1970) 0.75
[Achievements of nephrology in USSR during the 9th five-year plan and perspectives of its development]. Ter Arkh (1976) 0.75
[Clinico-pathogenetic aspects of Felty's syndrome]. Ter Arkh (1983) 0.75
[Clinico-immunological evaluation by a spectrophotometric method of determining cryoglobulins in rheumatic diseases]. Revmatologiia (Mosk) (1988) 0.75
[Tyrosine metabolism in systemic lupus erythematosus and therapeutic use of corticosteroid hormones. Preliminary report]. Ter Arkh (1974) 0.75
[Development of an autoimmune process against myocardial tissue in experimental berylliosis]. Gig Tr Prof Zabol (1971) 0.75
[Inhibitory effect of sera from patients with rheumatic diseases on EA-rosette formation]. Ter Arkh (1983) 0.75
[The age-related aspects of gouty nephropathy]. Ter Arkh (1991) 0.75
[Study of lymphocyte subpopulations and the expression of activation markers in diabetes mellitus types 1 and 2]. Klin Med (Mosk) (1989) 0.75
[Laboratory support for the immunological and allergological services in a general medical center]. Klin Lab Diagn (1996) 0.75
[The inhibiting effect of L-cysteine on the process of amyloid fibril formation in vitro and in vivo]. Biull Eksp Biol Med (1970) 0.75
[The immune system and nephropathies]. Ter Arkh (1984) 0.75
[Modern approaches to the problem of pyelonephritis]. Ter Arkh (1982) 0.75
[Characteristics of kidney disorders in lymphogranulomatosis]. Ter Arkh (1974) 0.75
[Factors associated with progression of kidney diseases and principal possibilities of affecting them]. Ter Arkh (1998) 0.75
[Disordered repair processes in patients with gouty nephropathy]. Ter Arkh (1986) 0.75
[Fibronectin in health and pathology]. Ter Arkh (1991) 0.75
[Diabetes mellitus--immunologic aspects]. Ter Arkh (1986) 0.75
[Senile pyelonephritis with the arterial hypertension syndrome: the use of trental]. Ter Arkh (1991) 0.75
[Immunological status in clinical medicine]. Ter Arkh (1982) 0.75
[Viral infection and immune mechanisms of the pathogenesis of diabetes mellitus type 1]. Ter Arkh (1989) 0.75
[Arterial hypertension in senile pyelonephritis: the renal hemodynamics]. Ter Arkh (1990) 0.75
[Immunopathologic concept concerning the pathogenesis of berylliosis]. Gig Tr Prof Zabol (1972) 0.75
[Effect of heterogenic antilymphocyte serum on the development of nephrotoxic nephritis in rats]. Biull Eksp Biol Med (1971) 0.75
[Sedimentation of circulating immune complexes with polyethylene glycol combined with immunoenzyme method--a new approach to analysis of circulating immune complexes in the sera of patients with rheumatic diseases]. Revmatologiia (Mosk) (1991) 0.75
[Normal antibodies to procollagen]. Zh Mikrobiol Epidemiol Immunobiol (1972) 0.75
[Determination of amyloid P component in blood by an immunoenzyme method]. Biull Eksp Biol Med (1989) 0.75
[Immunologic aspects of renal involvement in patients with type II diabetes mellitus]. Probl Endokrinol (Mosk) (1994) 0.75
[Senile pyelonephritis: the pathophysiology of the hypertension syndrome]. Ter Arkh (1993) 0.75
[Pneumocystic pneumonia with lethal outcome in male with Wegener's granulomatosis]. Ter Arkh (2000) 0.75
[Secondary amyloidosis in patient with Kaposi's sarcoma]. Ter Arkh (1999) 0.75
[Changes in leukocyte enzyme activity during experimental amyloidogenesis and in patients with amyloidosis]. Biull Eksp Biol Med (1976) 0.75
[Acute renal insufficiency in middle-aged and aged patients]. Ter Arkh (1987) 0.75
[Cellular immunity in glomerulonephritis]. Ter Arkh (1974) 0.75
[Circulating immune complexes in rheumatic diseases]. Ter Arkh (1981) 0.75
[Certain indicators of cellular immunity in amyloidosis (experimental clinical study)]. Sov Med (1975) 0.75
[Cytochemical changes in peripheral blood neutrophils in collagen diseases and nephropathies]. Vestn Akad Med Nauk SSSR (1970) 0.75
[Certain current problems of amyloidosis]. Ter Arkh (1974) 0.75
[Results of clinical-dispensary treatment of nephrological patients with renal function disorders]. Ter Arkh (1977) 0.75
[Hyperuricemia, gout and gout-induced nephropathy]. Ter Arkh (1980) 0.75
[Clinico-pathogenetic factors in the development of immune complex disease]. Ter Arkh (1980) 0.75
[Leukocyte migration inhibition as a method of detecting cellular hypersensitivity in autoimmune diseases]. Ter Arkh (1973) 0.75
[Blast transformation reaction in systemic lupus erythematosus]. Vestn Akad Med Nauk SSSR (1970) 0.75
[Amyloid transfer from a syngenous transplant of amyloid spleen in intact and amyloid mice]. Biull Eksp Biol Med (1978) 0.75
[Study of the nucleoprotein fraction of lung tissue in experimental berylliosis using gel filtration]. Vopr Med Khim (1989) 0.75
[Gerontological and geriatric problems of nephrology]. Ter Arkh (1981) 0.75
[Cellular aspects of immuno-inflammatory involvement of the kidneys]. Ter Arkh (1987) 0.75
[Renal lesions in elderly patients with diabetes mellitus]. Ter Arkh (1998) 0.75
[Pyelonephritis in old age]. Ter Arkh (1983) 0.75
[Endogenous opiate neuropeptides and the immune system]. Ter Arkh (1984) 0.75
[Achievements of nephrology in the 11th Five-Year Plan and its developmental prospects]. Ter Arkh (1986) 0.75
[The population aspects of renal arterial hypertension]. Ter Arkh (1997) 0.75
[Pathogenesis of amyloidosis]. Ter Arkh (1979) 0.75
[Amyloid resorption in the transplantation of the spleen into intact and amyloid recipients]. Biull Eksp Biol Med (1974) 0.75
[Achievements and problems in nephrology]. Ter Arkh (1984) 0.75
[Kidneys involvement in multiple myeloma. Therapeutic issues]. Klin Med (Mosk) (1997) 0.75
[Current approaches to immunological diagnosis of autoimmune and immune complex diseases]. Ter Arkh (1988) 0.75
[Kidney involvement in parasitic diseases]. Ter Arkh (1989) 0.75
[Kidney function following sustained late pregnancy toxemia]. Vopr Okhr Materin Det (1972) 0.75
[Behçet's disease in clinical practice]. Ter Arkh (1989) 0.75
[Image contrasting nephropathy in patients with NIDDM: risk factors]. Klin Med (Mosk) (1998) 0.75
[The cellular immunity indices in diabetic nephropathy]. Ter Arkh (1991) 0.75
[Current approaches to the problem of macrohematuria]. Ter Arkh (1982) 0.75
[Structure of the pathology of the senile kidney and its diagnostic difficulties]. Ter Arkh (1986) 0.75
[Acute-onset nephritis in middle-aged and elderly patients]. Ter Arkh (1985) 0.75
[Clinico-immunological parallels in berylliosis]. Klin Med (Mosk) (1973) 0.75
[Nephritis in middle-aged and elderly subjects]. Ter Arkh (1995) 0.75
[Blast transformation of lymphocytes in chronic kidney diseases]. Ter Arkh (1975) 0.75
[Effect of hemosorption on the level of circulating immune complexes in diseases of the internal organs (I)]. Ter Arkh (1982) 0.75
[A case of an attempt on the life of an individual by the use of a gamma irradiator]. Ter Arkh (1994) 0.75
[Diabetic and gouty nephropathies (certain aspects)]. Ter Arkh (1995) 0.75
[Blood tyrosine and the corticosteroid treatment of systemic lupus erythematosus]. Ter Arkh (1977) 0.75
[Tubulointerstitial nephritis and arterial hypertension--their clinical and population significance]. Ter Arkh (1997) 0.75
[Immunologic evaluation of a model of experimental berylliosis]. Biull Eksp Biol Med (1969) 0.75
[Changes in the antigenic composition of the lungs in experimental berylliosis]. Biull Eksp Biol Med (1972) 0.75
[Chromosomal instability related to disordered replication and repair processes of DNA synthesis in the cells of patients with gouty nephropathy]. Genetika (1988) 0.75
[Interrelation of autoimmune and immune complex pathology: the current status of the problem]. Ter Arkh (1984) 0.75
[Acute renal failure]. Ter Arkh (1980) 0.75
[The determination of the separate intrarenal hemodynamics and its place in the diagnosis of nephrogenic arterial hypertension]. Ter Arkh (1990) 0.75
[Development of nephrology in the USSR in the last 5-year period (Problem-solving Commission on Nephrology]. Ter Arkh (1981) 0.75
[Programmed hemodialysis in middle and old age]. Ter Arkh (1994) 0.75
[The epidemiological indices of multiple myeloma and concomitant nephropathies]. Ter Arkh (1997) 0.75
[Amyloidosis: several aspects of its clinical course and pathogenesis]. Ter Arkh (1977) 0.75
[Circulating immune complexes (PEG tests) in systemic lupus erythematosus]. Ter Arkh (1982) 0.75
[Cytochemistry of blood leukocytes in nephrotic syndrome of different etiology]. Ter Arkh (1974) 0.75
[Morphogenetic bases of an experimental therapy for amyloidosis]. Arkh Patol (1974) 0.75
[Quaternary structure of murine amyloid fibrils: fibril dissociation following exposure to sodium dodecyl sulfate and alkali]. Biull Eksp Biol Med (1980) 0.75
[Characteristics of the immune complex process in patients with systemic lupus erythematosus with predominant kidney involvement]. Ter Arkh (1986) 0.75
[Urinalysis in the history of medical diagnosis]. Ter Arkh (1998) 0.75
[Several indices of the state of cellular immunity in amyloidosis (experimental-clinical study)]. Sov Med (1975) 0.75
[Effect of levamisole on various indicators of cellular immunity in amyloidosis]. Ter Arkh (1978) 0.75